In Alzheimers disease, six-month treatment with GLP-1 analogue prevents decline of brain glucose metabolism: randomized, placebo-controlled, double-blind clinical trial
Muscle loss is a significant practical concern, with studies showing that 30-40% of weight lost on GLP-1 agonists can be lean mass if protein intake and resistance training are neglected
The urge to engage in bad behavior is similar to obsessive compulsive disorder (OCD), Dr
The lawsuit, filed in federal district court in New Jersey, alleges Lilly intentionally selected outdated studies to show the use of Mounjaro and Zepbound lead to significantly more weight loss than Novo Nordisks Ozempic and Wegovy
The working theory is that there are GLP-1 receptors in the parts of the brain that are involved with desire for food intake and alcohol intake, Thiara says